Andreu Llorente

Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]

G Perea, Adriana Lasa, Neus Villamor et al. · Leukemia · 2005 · 160 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +11

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML

Josep Nomdedéu, Montserrat Hoyos, Maite Carricondo et al. · Leukemia · 2013 · 72 citations

Hematological Malignancy, Medicine, Hematology +5

Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia

Mariano Monzó, Salut Brunet, Álvaro Urbano-Ispizúa et al. · Blood · 2006 · 70 citations · Full text

Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status

Josep‐María Ribera, Olga García, Carlos Grande et al. · Cancer · 2013 · 69 citations · Full text

Postpartum ovarian vein thrombosis

Arancha Ugarriza, Rosa Espax, Jordi Boixadera et al. · Thrombosis and Haemostasis · 2005 · 52 citations

Thrombosis, Venous Thrombosis, Postpartum Hemorrhage +6